Bayer shows profit rise

May 2006
ICIS Chemical Business;5/8/2006, Vol. 1 Issue 18, p10
Trade Publication
The article reports on the increase in the operating profit of Bayer in the first quarter of 2006. The Healthcare and MaterialScience units contributed to the operating profit. There is an 11.8% rise in sales generated by the company.


Related Articles

  • Bayer net quadruples to $1.7 b in Q3.  // Chemical Business;Nov2007, Vol. 21 Issue 11, p88 

    The article reports on the strong financial performance of drug and chemical manufacturer Bayer for the third quarter of 2007. Bayer also announced its plan to cut 1,500 jobs at its MaterialScience unit worldwide as it aims to reduce expenses through 2009. The company earned €1.18 billion...

  • COMPANY SPOTLIGHT - Bayer AG.  // PharmaWatch: Biotechnology;Feb2006, Vol. 5 Issue 2, p22 

    The article focuses on the operations and strategies of the biotechnology company, Bayer AG. The company has received approval from the United States Food and Drug Administration for its Nevaxar tablets for the treatment of patients with advanced renal cell carcinoma, which has been developed in...

  • Bayer Posts its Best Annual Results, But Idles PC Plants. Alperowicz, Natasha // Chemical Week;3/9/2009, Vol. 171 Issue 7, p13 

    The article reports on the financial performance of Bayer in the fourth quarter of 2008. The company posted a 58 percent increase in net profits to $135 million. On the other hand, the Bayer MaterialScience (BMS) business posted an operating loss for the fourth quarter, undermining stronger...

  • COMPANY SPOTLIGHT - Bayer AG.  // PharmaWatch: Monthly Review;Jun2006, Vol. 5 Issue 6, p41 

    The article features Bayer AG, a chemicals and pharmaceutical group represented by about 350 individual companies. The group's business segments are Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The company also provides service functions through three service companies: Bayer...

  • Bayer to Double Sales in China; May Add Products at Caojing. Alperowicz, Natasha // Chemical Week;11/9/2005, Vol. 167 Issue 37, p19 

    Reports on the decision of Bayer to build a chemical complex in Shanghai, China in an effort to double its sales in the region. Value of investments provided by Bayer MaterialScience for the complex; Production capacity of the plant; Details of the investment efforts of Bayer CropScience and...

  • Bayer Reports Higher Sales and Earnings Confirms Full-Year Outlook. ALPEROWICZ, NATASHA // Chemical Week;10/24/2011, Vol. 173 Issue 26, p16 

    The article deals with the increased earnings and sales posted by U.S. chemical firm Bayer for the third quarter of 2011. It says that the excellent performance of its Bayer CropScience and HealthCare subgroups contributed a lot to its overall financial state. According to the author, the high...

  • Bayer continues on a path of growth.  // Chemical Business;Sep2007, Vol. 21 Issue 9, p87 

    The article reports on the continued sales growth of the Bayer Group in the second quarter of 2007. The growth of the company stood at 22% to EUR8,217 million. Bayer also obtained a 38.6% increase in earnings before interest, taxes, depreciation and amortization (EBITDA). There was an...

  • Bayer keeps pushing MaterialScience. Davis, Nigel; Chang, Joseph // ICIS Chemical Business Americas;3/26/2007, Vol. 271 Issue 12, p20 

    The article focuses on the tough targets set by Bayer for its MaterialScience business, which has helped the group through a difficult period of realignment. The pharmaceutical business of Bayer is worth close to €10 billion and is expected to grow strongly. It cites that the performance...

  • Bayer profits up, spin-off on track, reorganization pending.  // Chemical Week;3/2/2015, p13 

    The article focuses on the quarterly and annual sales performance of chemical and health care product manufacturer Bayer according to its report in February 2015. Topics discussed include various key indicators including its net income, earnings before interest taxes (Ebit), and earnings per...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics